AN2 Therapeutics Ownership & Insider Activity

AN2 Therapeutics Inc

ANTXNASDAQ

$3.53

-0.11-3.02%

最終更新: Oct 23, 9:30 AM

AN2 Therapeutics Ownership & Insider Activity - Benzinga

AN2 Therapeutics (ANTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Purchases (90d)

$12K total

Sales (90d)

$318K total

Net Activity

Net Selling

Net Value (90d)

-$307K

Date	Insider	Title	Type	Shares	Price	Value
Sep 9, 2026	Robin Shane Readnour	—	SELL	1.108K	$6.02	$7K
Sep 3, 2026	Robin Shane Readnour	—	SELL	16.119K	$6.04	$97K
Sep 1, 2026	Sarah Joanne Williams	PRINCIPAL ACCOUNTING OFFICER	SELL	272.000	$5.53	$2K
Sep 1, 2026	Margaret M FitzPatrick	—	BUY	2.098K	$5.53	$12K
Aug 17, 2026	Robin Shane Readnour	—	SELL	35.402K	$6.01	$213K
Jul 8, 2026	Joshua M Eizen	SEE REMARKS	SELL	5.945K	$4.17	$25K
May 29, 2026	Sarah Joanne Williams	PRINCIPAL ACCOUNTING OFFICER	SELL	265.000	$4.43	$1K